A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations
Clinical trial NCT03434418 · COMPLETED
Trial details
- NCT number
- NCT03434418
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-30
- Primary completion
- 2022-10-12
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.